Delivery Order SPE2DB20D1109-SPE2DB25FP79L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,743.48 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/ml. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by August 27, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,019.16 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on April 22, 2025, with an ultimate completion date of April 23, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.36 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,925.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on April 22, 2025, with completion targeted for April 23, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- This delivery order, awarded August 29, 2025, grants AmerisourceBergen Drug Corp a $1,449.00 firm fixed price contract for Testosterone Cypionate 200 mg/mL, with completion scheduled for September 2, 2025. The award was issued by the Defense Logistics Agency under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL with a ceiling value of $1,022.57. This firm fixed-price delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. The...
- This delivery order, valued at $1,416.00, was awarded to AmerisourceBergen Drug Corp on August 5, 2025, by the Defense Logistics Agency (DLA) for the supply of Testosterone Cypionate 200 mg/mL. The contract is a firm fixed-price delivery order with performance scheduled to conclude on August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside designation was applied to this competitive...
- The Defense Logistics Agency awarded a delivery order valued at $3,460.46 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child contract under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP79LDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,679.78 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Testosterone Cypionate 200 mg/mL. The contract is not set-aside and employs firm fixed-price pricing with an ultimate completion date of September 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has demonstrated significant capability in meeting federal medical procurement requirements through competitive open competition across multiple therapeutic domains. The company's federal contract portfolio includes an extensive range of pharmaceutical products such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies serving various federal customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for testosterone cypionate represents a routine transaction within the contractor's established relationship with DLA, supporting the military healthcare supply chain with critical pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/19/25 |